Clinical Trial Update: Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population [Phase 4]

View source ↗

Summary

Phase 4 trial comparing blood pressure reduction with aliskiren/HCTZ versus HCTZ alone in older adults with stage 2 systolic hypertension; results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-01-21